A catalog of all human protein-protein interactions would provide scientists with a framework to study protein deregulation in complex diseases such as cancer. Here we demonstrate that a probabilistic analysis integrating model organism interactome data, protein domain data, genomewide gene expression data and functional annotation data predicts nearly 40,000 protein-protein interactions in humans⎯a result comparable to those obtained with experimental and computational approaches in model organisms. We validated the accuracy of the predictive model on an independent test set of known interactions and also experimentally confirmed two predicted interactions relevant to human cancer, implicating uncharacterized proteins into definitive pathways. We also applied the human interactome network to cancer genomics data and identified several interaction subnetworks activated in cancer. This integrative analysis provides a comprehensive framework for exploring the human protein interaction network.
We began by assembling a collection of genomic and proteomic data potentially useful in predicting human protein-protein interactions that included model organism protein-protein interactions 1 , protein domain assignments 2 , gene expression measurements in human tissue samples 3 and biological function annotations 4 (Table 1) . Based on previous reports, we suspected that (i) model organism interactions may suggest interactions among orthologous human proteins 5, 6 , (ii) similar gene expression profiles across a panel of human tissue samples may identify interacting protein products 7, 8 , (iii) protein domain pairs enriched among known human protein-protein interactions may suggest novel interactions 9 , (iv) shared functional annotations from Gene Ontology 4 may suggest physical interactions, and (v) that combining evidence from independent data sources may strongly predict protein-protein interactions [10] [11] [12] . To test these hypotheses, we applied a naive Bayes classifier 7 , a method well-suited for integrating disparate data types.
A gold standard positive set (GSP) of 11,678 distinct protein-protein interactions among 5,505 proteins was queried from the Human Protein Reference Database (HPRD) 12 , a resource that contains known protein-protein interactions manually curated from the literature by expert biologists. A gold standard negative set (GSN) of 3,106,928 protein pairs was defined, in which one protein was assigned to the plasma membrane cellular component and the other to the nuclear cellular component by the Gene Ontology Consortium 4 . Although it is known that membrane proteins can occasionally interact with nuclear proteins, we demonstrated that there are far fewer known interactions within GSN than would be expected by chance (Supplementary Methods online). By averaging the number of interactions per protein in the GSP, we estimated the prior odds of interaction among two randomly selected proteins to be 1 in 381. This is likely an underestimate of the true prior odds because all protein-protein interactions are not known; however, to err on the conservative side, we assumed the estimate to be true. To achieve posterior odds (O post ) greater than 1 (that is, a >50% chance of interaction), the likelihood ratio cutoff (LR cut ) must be set at 381. In the following sections, we systematically test the predictive data sets against the GSP and GSN, generating likelihood ratios, and then we combine the data set-specific likelihood ratios (LR) in a naive Bayes model, which is applied to all protein pairs to predict novel human protein-protein interactions. Contingency tables detailing the intersection of predicted interactions with the GSP and GSN sets and the resultant likelihood ratios are provided online as Supplementary Tables 1-8.
Figure 1
Diverse genomic and proteomic data sources contribute to the predictive modeling of human protein-protein interactions. (a) Model organism interaction data was downloaded from the DIP and model organism proteins were mapped to human orthologs using the Inparanoid database. All pairs of human proteins that corresponded to orthologs reported to interact were compared with the GSP and GSN interactions to generate likelihood ratios. A decision tree algorithm was used to bin predicted interactions into high (H), medium (M), and low (L) confidence groups when possible. (b) Coexpression predicts human proteinprotein interactions. Five large gene expression data sets were selected from the Oncomine database based on predictive strength. Pairwise gene correlation matrices were calculated for each data set. (c) Shared biological function predicts human protein-protein interactions. For each pair of proteins, as a measure of functional similarity, the SSBP was identified and then gene pairs were binned based on this number. The likelihood of human protein-protein interactions increases as the size of the SSBP decreases. (d) Pairs of domains enriched among pairs of proteins known to interact were identified, ascribed a domain enrichment score (DES), binned by this score and tested against the GSP and GSN (i). Because the shared biological function and domain enrichment data sources were found to be somewhat redundant, protein pairs with both evidence sources were analyzed in conjunction; a decision tree algorithm grouped protein pairs with both evidence types into five bins based on the size of the SSBP and DES (ii).
to 6,864 human proteins, predicting 17,109 orthologous human interactions. Of 1,805 possible GSPs, we predicted 118 (6.5%) to interact, in contrast to 392 of 199,640 (0.19%) GSNs (LR = 33.3). Finally, the CE data had 4,008 interactions among 2,100 distinct proteins, which mapped to 1,181 human proteins, predicting 2,895 orthologous human interactions. Of 144 possible GSPs, we predicted 12 (8.3%) to interact in contrast to 49 of 12,222 (0.40%) GSNs (LR = 20.8). In summary, model organism interactions are moderately predictive of orthologous human protein interactions, although none of the model organism data sets reach the likelihood ratio threshold of 381. The SC data were found to be most predictive, likely owing to multiple semi-redundant experimental data sources as opposed to single data sources for DM and CE.
Next we examined parameters associated with the model organism interactions and tested their ability to stratify the predicted human interactions into confidence bins. These parameters included ortholog mapping confidence scores from Inparanoid, the number of human interactions predicted per model organism interaction, the number of evidence types in the case of the SC data, and an interaction confidence score in the case of the DM data. To derive logical bins associated with these parameters, we used a decision tree algorithm 20 . The interactions predicted from the SC data were grouped into four bins: a high-confidence bin, in which the SC interactions had more than one evidence type (for example, yeast two-hybrid and immunoprecipitation; n = 3,248; LR = 1,664.8), a medium-high confidence bin, in which a single human interaction was predicted 2), a medium confidence bin, in which more than one but less than 28 human interactions were predicted per SC interaction (n = 9,008; LR = 67.0), and a low-confidence bin, in which more than 28 human interactions were predicted per SC interaction (n = 6,725; LR = 9.8). The DM data were divided into two bins: a medium-high confidence bin, in which the DM interactions had a confidence score greater than 0.55 (n = 3,088; LR = 324.4), and a low confidence bin, in which the confidence score was less than 0.55 (n = 14,030; LR = 9.2). The decision tree algorithm did not stratify the interactions predicted from the CE data. We also created a separate bin for 201 predicted human protein interactions that were predicted by two model organism data sets (n = 201; LR = 1664.8; Fig. 1a ).
Gene expression
Although it is well known that interacting proteins are often coexpressed, it is unclear if data on coexpression can be used to predict human protein-protein interactions. We identified coexpressed genes from 65 genome-wide gene expression data sets present in the Oncomine Cancer Microarray Database 3, 21 . The 65 data sets consisted of more than 5,000 diverse microarray profiles representing many tissue types, differentiation states and cellular compositions, thus covering a broad spectrum of gene expression (Supplementary Table 2 ). For each data set, we calculated Pearson correlations for each pair of genes and then grouped gene-pairs into 19 correlation bins. Likelihood ratios were then calculated for each correlation bin in each data set. Nearly all data sets had a weak positive association between coexpression and protein interactions. In five selected data sets, each of which profiled more than 80 human tissue samples, the likelihood ratios were considerably stronger and increased consistently with increasing coexpression (Fig. 1b and Supplementary Table 3 ).
Shared biological function
Two proteins that function in the same biological process (for example, the cell cycle) should be more likely to interact than two proteins that do not. Furthermore, proteins functioning in small, specific biological processes should be more likely to interact than proteins functioning in large, general processes (for example, mitotic spindle checkpoint versus cell proliferation). We downloaded biological process annotations from the Gene Ontology Consortium 4 and compressed the hierarchy to derive 94,045 assignments of 9,345 proteins to one or more of 1,887 biological processes. Next, as a measure of functional similarity, we identified the smallest shared biological process (SSBP) for each pair of annotated proteins, binned protein pairs by this measure, and then generated likelihood ratios for each bin by testing against the GSP and GSN. As expected, protein pairs with shared biological function annotations were more likely to interact than those without shared annotations, and protein pairs that shared small, specific functional annotations were more likely to interact than pairs sharing large, general annotations ( Fig. 1c and Supplementary Table 4 ). For example, protein pairs that shared a biological function annotation with more than 10 but fewer than 50 total proteins were far more likely to overlap with the GSP (6.9%) Step 1 was to calculate likelihood ratios for groups of predictions based each data type ( Fig. 1) .
Step 2 was to identify data types that contain redundant information and then calculate likelihood ratios for predictions with both data types (shared biological function and enriched domain pair).
Step 3 was to identify the maximum likelihood ratio, max(LR), from each evidence type.
Step 4 was to multiplicatively combine likelihood ratios in a naive Bayes model to generate composite likelihood ratios (LR comp ). Gene expression data sets: Br, Breast; Li, Liver; Ly, Lymphoma; M, Multi-cancer; Sa, Sarcoma.
A N A LY S I S than with the GSN (0.037%), generating a moderately strong predictor of protein interactions (LR = 188.8).
Protein domains
Because protein interactions involve physical associations between protein domains, it has been proposed that novel protein interactions may be predicted by identifying pairs of domains enriched among known interacting proteins 9 . To test this logic in the context of our GSP and GSN sets, we downloaded the Interpro database, which consisted of 19,438 assignments of 1,352 protein domains and families to one or more of 9,779 proteins. To quantify the co-occurrence of particular domain pairs among interacting proteins, we devised the domain enrichment ratio (D). Because the identification of predictive domain pairs requires a large set of known protein interactions, we divided the GSP into thirds, and used two thirds of the GSP to define enriched domain pairs and the remaining third to test the ability of the enriched domain pairs to predict new interactions. We repeated this process three times and combined the results. We found that the degree of domain enrichment in two thirds of the GSP is strongly associated with the likelihood of interaction in the remaining third ( Fig. 1d and Supplementary We suspect that many of the enriched domain pairs represent physically interacting domains; however, it is also possible that the cooccurrence is due to indirect interactions. A complete list of enriched domain pairs is available as Supplementary Table 6 online.
Integrative analysis: naive Bayes classifier
Thus far, we have predicted a large number of protein-protein interactions with low confidence and a small number of interactions with high confidence. To predict a larger number of protein-protein interactions with high confidence, we probabilistically combined the evidence sources in a naive Bayes model, which multiplicatively combines the data set-specific likelihood ratios. This multiplicative nature requires that the predictive data sets be conditionally independent or nonredundant. We found that the four types of evidence were essentially independent, except for the shared biological function and enriched domain pair evidence types, which were found to contain redundant information (Supplementary Methods and Supplementary Table 8 online) . To avoid bias, we computed separate likelihood ratios for protein pairs having predictive evidence from both data sources. Using a decision tree algorithm, we created five bins: a high confidence bin containing protein pairs with strong domain pair enrichment (D > 10) and some degree of functional similarity (SSBP < 1,000; n = 4253; LR = 19,381), a medium-high confidence bin containing protein pairs with moderate domain pair enrichment (3 < D < 10) and some degree of similarity in biological function (SSBP < 1000; n = 1 6,348; LR = 495.6), another medium-high confidence bin containing protein pairs with weak domain pair enrichment (2 < D < 3) but strong functional similarity (SSBP < 100; n = 4,117; LR = 407.2), and finally, two low confidence bins ( Fig. 1d and Supplementary Table 8 ).
The predictive data sets were combined in a naive Bayes model, which was applied to all protein pairs, automatically combining available evidence sources to derive composite likelihood ratios (LR comp ; Fig. 2 ). This resulted in the prediction of 39,816 interactions at a likelihood All human protein-protein interactions estimate ~ 300,000 Table 9 online). Figure 3a relates predicted interactions at various confidence levels with the GSP interactions and the estimated superset of all human protein-protein interactions. The result of nearly 40,000 predicted interactions with a false positive rate of 50% and more than 10,000 predicted interactions with a false positive rate of just 20% is comparable or superior to the results of highthroughput experimental approaches in model organisms [13] [14] [15] [16] [17] [18] . To examine the validity of this model, we binned predicted interactions by LR comp and assessed the true likelihood ratios for each bin, based on the intersection with the GSP and GSN (Fig. 3b and Supplementary Table 10 online). As anticipated, the true likelihood ratios closely parallel the LR comp measure provided by the model, confirming that the multiplicative nature of the model does not overestimate the likelihood of interaction in the training set. Next, we assessed the model on an independent test set of 5,784 known interactions that were queried from the Human Protein Reference Database after the model was built. As shown in Figure 3c , the model performs similarly on the training and test sets, suggesting that our model provides a valid measure of the odds that two proteins interact. 
Network analysis and experimental validation
To explore the complex interaction circuitry among human proteins at the level of a single protein or pathway, we created a public bioinformatics resource, Human Interactome Map or HiMAP (http://www. himap.org). Using HiMAP, we investigated two specific areas of the interactome map and identified intriguing predicted interactions, which we later confirmed experimentally. First, we sought to identify previously unknown components of the mitotic spindle checkpoint, as this pathway is important in aneuploidy and cancer 22, 23 . Beginning with several well characterized members of the mitotic spindle checkpoint (CDC20, BUB1 and BUB3, among others), we found many novel predicted interactions, including one between BUB3 and ZNF207, an uncharacterized zinc finger protein (Fig. 4b) . Next, we seeded HiMAP with a protein of interest, RSU1, which is a potential tumor suppressor, whose gene is down-regulated in prostate cancer [24] [25] [26] . Because the mechanism by which RSU1 exerts its tumor suppressor effects remain to be elucidated, we sought to implicate this protein in a specific pathway. HiMAP analysis revealed that RSU1 was predicted to interact with LIMS1 which forms a ternary complex with ILK (integrin-linked kinase) and NCK2 and has been shown to colocalize with integrins 27 (Fig. 4c) . Well-characterized members of the respective pathways are designated with dark blue circles and experimentally confirmed new members with red circles. ZNF207 was predicted and experimentally confirmed to interact with BUB3, potentially implicating this uncharacterized zinc finger transcription factor in the mitotic checkpoint pathway (b). RSU1 was predicted and experimentally confirmed to interact with LIMS1, an integrin-mediated signaling adaptor protein, downstream of integrins and integrin-linked kinase, suggesting a pathway through which RSU1 may exert its documented tumor suppressor effects (c).
A N A LY S I S
Using coimmunoprecipitation assays, we confirmed the predicted interactions between BUB3 and ZNF207 and between RSU1 and LIMS1 (Fig. 5a) . To validate the biological relevance of these interactions, we also demonstrated colocalization by confocal microscopy (Fig. 5b) . The BUB3-ZNF207 interaction is notable because it represents a new link between the well-established mitotic spindle checkpoint pathway and an uncharacterized zinc finger transcription factor that, to date, had not been expressed or characterized at the protein level 28 . The RSU1-LIMS1 interaction is notable because it implicates a potential tumor suppressor protein (RSU1) in the integrin signaling pathway. RSU1 was originally identified in a screen for genes that could inhibit Ras-mediated signaling 29 and was later shown to inhibit anchorage-independent growth of MCF7 breast cancer cells 30 . Notably, we have observed that RSU1 is consistently downregulated in prostate cancer 3, 24, 26 , further suggesting a tumor suppressor role for this gene; however, to date, the mechanism by which RSU1 exerts its effects has not been elucidated. Here our model predicted, and we experimentally confirmed that RSU1 interacts with LIMS1, an adaptor protein involved in integrin signaling at focal adhesions 31 . Furthermore, we found that when RSU1 was expressed alone, it had diffuse cytoplasmic localization, but when it was coexpressed with LIMS1, it had discrete punctate cytoplasmic localization (Fig. 5c) . These results are consistent with the localization of LIMS1 to focal adhesions and demonstrate that LIMS1 recruits RSU1 to focal adhesions, suggesting that RSU1 may exert its effects through LIMS1 and the integrin signaling pathway.
Next we explored the utility of the known and predicted interactome networks for interpreting cancer gene expression data. We generated protein interaction subnetworks for genes overexpressed in pancreatic adenocarcinoma, multiple myeloma and renal cell carcinoma, as defined by Oncomine 3 . In pancreatic adenocarcinoma, we found an oncogenic tyrosine kinase subnetwork involving ERBB2, MUC1, SHC1 and EPH2A and an invasion signaling subnetwork involving NET1, RhoA, RhoC and RAC (Supplementary Fig. 2 online) . RhoA, RhoC and RAC are all small G-protein signaling molecules with known roles in cell migration and metastasis [32] [33] [34] , whereas NET1 is a guanine nucleotide exchange factor, which activates RhoA and RhoC 35 and has transforming ability on its own 36 . Perhaps overexpression of this subnetwork is responsible for the invasive properties of pancreatic adenocarinoma. In multiple myeloma, we identified an activated oncogenic signaling subnetwork involving H-RAS, RAF1, BAG1 and PAK1 (Supplementary Fig. 3 online) . H-RAS is a small GTPase that undergoes activating mutations in several cancers 37 , whereas RAF1 is a downstream mediator of H-RAS signaling that on its own can induce RAS-like tumorigencity 38 . Also, BAG1 and PAK1 are capable of binding to and activating RAF1 39, 40 . Finally, in the clear cell variant of renal cell carcinoma, we identified an oncogenic subnetwork of activated proteins including VEGF, KDR, PDGFB, PDGFRB, SHC, MAPK1, CSF1R, FYN and LYN ( Supplementary  Fig. 4 online) . This subnetwork is unique because it includes two overexpressed receptor ligand pairs, suggesting active autocrine signaling loops.
In summary, we have integrated disparate genomic and proteomic data sources to develop a model for predicting human protein-protein interactions on a global scale. Whereas previous studies have attempted A N A LY S I S to infer protein interactions from genomic data sources 6,41 , we have built a robust, comprehensive and presumably more accurate predictive model by probabilistically combining several independent data sources and calculating reliable confidence measures by rigorous testing against large sets of gold standard positive and negative interactions. Furthermore, we proved the validity of our model on an independent test set of known interactions and experimentally confirmed two predicted interactions, expanding the mitotic spindle checkpoint pathway and implicating a potential tumor suppressor gene in the integrin signaling pathway. We have also built HiMAP for analyzing the known and predicted components of the human interactome. Lastly, we demonstrated the utility of the human interactome for interpreting genome-wide gene expression data in complex human diseases such as cancer. We anticipate that the predictive model will grow in size and accuracy as the GSP set is expanded and as new predictive evidence sources become available.
METHODS
Detailed methods. Additional methods are available in Supplementary Methods online.
Gold standard interactions. The GSP interaction set was downloaded from the HPRD (http://www.hprd.org). In January, 2004, 11,678 interactions among 5,505 proteins, and the literature references were downloaded from HPRD. Later, in August, 2004, 5,784 new interactions were downloaded, which were used as the independent test set. None of the test set interactions were part of the training set. The GSN interaction set was defined as all protein pairs in which one protein was assigned the plasma membrane cellular component (1, 426 proteins) and the other the nuclear cellular component (2, 253) , as assigned by Gene Ontology Consortium. Twenty-nine proteins that were assigned to both components were removed. In total, 3,106,928 unique pairs were identified.
Integrated data sets. Publicly available model organism protein interaction data sets were downloaded from the DIP (http://dip.doe-mbi.ucla.edu/ dip/Download.cgi). Pairwise ortholog map files were downloaded from the Inparanoid database (http://inparanoid.cgb.ki.se/). Logical bins based on several parameters associated with the predicted interactions were defined using the J48 decision tree algorithm as implemented in the Weka software package 20 (http//www.cs.waikato.ac.nz/ml/weka). To identify genes that are coexpressed, publicly available microarray data were collected from the Oncomine Cancer Microarray Database (http://www.oncomine. org). Sixty-five data sets were available and analyzed independently. Pearson correlations were computed between all pairs of genes with values present in 50% of the profiled samples, and then gene pairs were grouped into 19 correlation bins of increasing coexpression. Five data sets were selected for the final analysis: a multicancer data set profiling of 174 cancer samples of 11 tissue types 42 , a breast cancer data set profiling 117 breast tumors 43 , a liver data set profiling 197 normal and cancerous liver samples 44 , a lymphoma data set profiling 293 lymphoma samples 45 and a soft-tissue data set profiling 81 melanomas and soft-tissue tumors 46 . Biological process annotations were downloaded from the Gene Ontology Consortium 4 and compressed the hierarchy to derive 94,045 assignments of 9,345 proteins to one or more of 1,887 biological processes. The SSBP per pair of proteins was defined. Protein domain and family assignments were downloaded from the Interpro database. In total, 19,438 assignments of 1,352 protein domains and families to one or more of 9,779 proteins were queried. Domain pair enrichment was assessed with the domain enrichment ratio (D), which is calculated as the probability (Pr) of observing a pair of domains in a set of known interacting proteins divided by the product of the probabilities of observing each domain pair independently:
where d i and d j are two protein domains, d i :d j is a protein-protein interaction in which one protein has d i and one has d j , and GSP is a gold standard positive set of known interactions. We also ensured that a minimum representation of at least three interactions was present in the GSP set.
Naive Bayes classifier approach. Following a derivation of Bayes rule, the posterior odds of interaction (O post ) can be calculated as the product of the prior odds of interaction (O prior ) and the likelihood ratio, L (f1). The prior odds being the chance of choosing a pair of interacting proteins from all protein pairs and the likelihood ratio being the probability of observing the values in the predictive data sets given that a pair of proteins interacts divided by the probability of observing the values given that the pair does not interact (f2). In the special case in which the predictive data sets are conditionally independent or nonredundant, the likelihood ratio can be calculated as the product of individual data-set likelihood ratios (f3). Formally stated:
where L is the likelihood ratio, f is a protein pair's value in data sets i, GSP is a gold standard positive set of known interactions, and GSN is a gold standard negative set of protein pairs that do not interact. The prior odds of interaction were defined as:
where P(pos) is the probability of finding an interacting pair of proteins among all pairs of proteins, and P(neg) is the probability of finding a noninteracting pair. The prior odds were estimated by examining the average number of interactions per protein for which all known interactions were identified in the literature. Among 2,987 proteins, 11,678 distinct interactions existed, thus the probability that two randomly selected proteins interact was calculated to be 1 in 382. The posterior odds or the odds that two proteins interact given new predictive evidence were defined as:
Where f i is a protein pair's value in data set i. The likelihood ratio:
Relates the prior odds and the posterior odds as defined by a derivation of Bayes rule:
When the evidence types integrated are independent (or non-redundant), the likelihood ratio can be calculated simply as the product of individual likelihood ratios from the respective evidence types. This is known as a Naive Bayes Network:
Because the Shared Biological Function and Domain Enrichment evidence types were found to be semiredundant, they were analyzed together, so that only one likelihood ratio was submitted from these two data sources. Also, because coexpression in multiple data sets was found to be redundant information, only the largest coexpression likelihood ratio was submitted to the model.
Interaction network graphing.
The HiMAP web application (http://www. himap.org) was developed to dynamically visualize and explore a database of protein interactions. The application was written in Java and uses an Oracle 9i database. The r-PolyLog energy model was implemented to lay out interaction networks, and the networks are displayed with scalable vector graphics (SVG). We created Figure 4a with Cytoscape 47 (http//www.cytoscape.org). A N A LY S I S Open reading frame cloning and coaffinity purification experiments. Fulllength, sequence-verified mammalian gene collection (MGC) clones (Open Biosystems) were obtained for the indicated proteins and Gateway-cloned essentially as described 48 . Clones and primer sequences used for amplification are available in Supplementary Table 11 online. ORFs were amplified using adapter PCR and cloned into the Gateway vector pDNR221 (Invitrogen). Entry clones of bait proteins were subcloned into pDEST-27, which contains the glutathione S-transferase (GST) epitope tag upstream of a Gateway recombination site (gift of A. Swaroop, University of Michigan Medical School). Entry clones of prey proteins were subcloned into pCMV-Myc-DEST, which contains a Myc epitope tag upstream of the Gateway recombination site (Kind gift of J. W. Harper, Harvard Medical School).
For co-affinity purification experiments, 1 µg of each plasmid was transfected into 293T cells using Fugene 6 reagent according to the manufacturer's instructions (Roche). For GST control plasmids, 0.5 µg of each plasmid was used per transfection. Cells were cultured for 2 d in RPM1 medium with 10% fetal bovine serum (Invitrogen) and lysed in 0.5% NP-40 buffer (20 mM TrisHCl (pH 8.0), 100 mM NaCl, 1 mM EDTA and complete protease inhibitor cocktail (Roche)). Lysates were cleared by centrifugation at 14,000g before precipitation of protein complexes using glutathione-Sepharose beads. Beads were washed three times with lysis buffer, and purified complexes and control lysate samples were separated on acrylamide gels (Bio-Rad). Myc-and GSTtagged proteins were detected using standard immunoblotting techniques. Primary antibodies used were mouse monoclonal anti-Myc (clone 9E10, Cell Signaling Technology) and rabbit polyclonal anti-GST (Sigma).
Immunofluorescence and confocal microscopy. The breast carcinoma cell line MCF-7 was grown on chamber slides (Lab-Tek) overnight in RPMI medium and transfected with Myc-tagged or GST-tagged clones alone in individual chambers or cotransfected with both clones for 36 h. Cells were washed and fixed using chilled methanol. The slides were then blocked in PBS-T (phosphate-buffered saline with Tween-20 (0.01%) with 5% normal donkey serum for 1 h. A mixture of rabbit anti-GST (Sigma) and mouse antiMyc (Cell Signaling Technology) was added to the slides at 1:500 and 1:1,000 dilutions, respectively, and incubated for 1 h at 15-25 °C. Slides were then incubated with secondary antibodies (anti-rabbit Alexa 488 and anti-mouse Alexa 555 (Molecular Probes) at 1:1,000 dilution) for 1 h. After washing the slides with PBS-T and PBS, the slides were mounted using VECTASHIELD mounting medium containing DAPI (4',6-diamidino-2-phenylindole; Vector Laboratories). Confocal images were taken with a Zeiss LSM510 META (Carl Zeiss) imaging system using ultraviolet, argon and helium neon 1 light source. The triple color images were exported as TIFF images.
Note: Supplementary information is available on the Nature Biotechnology website.
